Skip to main content

Table 1 The results of laboratory test of the blood and the bronchoalveolar lavage fluid (BALF)

From: Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease

  Case1 Case2
Blood examination
 WBC (/μL) 6,800 4,500
 CRP (mg/dL) 0.02 0.03
 LDH (IU/L) 222 202
 SP-D (ng/mL) 37 19.3
 KL-6 (IU/mL) 299 211
 β-D-glucan (pg/mL) negative negative
 CMV antigen pp65 C7-HRP (antigenemia) negative negative
BALF
 Fluid (mL) 17/100 23/150
 cell count (/mL) 4 × 105 1 × 105
 Lymphocyte (%) 54.5 17
 Neutrophil (%) 1 25
 Eosinophil (%) 5 1
 Basophil (%) 0 0
 Histiocyte (%) 39.5 57
 CD4/CD8 rate 1.2 0.65
culture negative negative
Arterial blood gas
 pH 7.396 NA
 PaO2 (mmHg) 36.0 NA
 PaCO2 (mmHg) 82.5 NA
 HCO3 - (mmol/L) 21.6 NA
 BE −2.2 NA